The Bioabsorbables/Bioresorbables Center

Filter Your Results




First-in-Man BIOSOLVE-II Evaluates Biotronik’s Next-Generation Bioresorbable Stent

October 12, 2015 -- Results from BIOSOLVE-II, a first-in-man study examining 6-month angiographic and clinical outcomes of Biotronik AG’s newest iteration of a bior…

FDA Approves Boston Scientific’s Synergy Bioabsorbable Polymer DES System

October 5, 2015 -- Boston Scientific Corporation announced US Food and Drug Administration (FDA) approval for the Synergy bioabsorbable polymer, drug-eluting stent system (BP-…

Two-Year Data Published for DESSOLVE Trials of Micell's MiStent

October 5, 2015 -- Two-year outcomes from the DESSOLVE I and DESSOLVE II trials of the bioabsorbable polymer-coated, sirolimus-eluting coronary MiStent (Micell Technologi…

Abbott Vascular’s Absorb BVS Demonstrates Noninferiority to Xience DES in STEMI Patients

September 1, 2015 -- The European Society of Cardiology announced that Prof. Patrick W. Serruys, MD, presented findings from ABSORB STEMI: the TROFI II trial at the ESC Congre…

FAST Enrollment Begins for Boston Scientific’s Fully Resorbable Drug-Eluting Scaffold

July 20, 2015 -- Boston Scientific Corporation has initiated the Fully Absorbable Scaffold Feasibility Study (FAST) of the company’s first fully resorbable drug-eluting …

ART’s Bioresorbable Scaffold Receives CE Mark Clearance

May 18, 2015 -- Arterial Remodeling Technologies (ART) has announced European CE Mark clearance for its next-generation, drug-free, pure bioresorbable scaffold for the tr…

Twelve-Month EVOLVE II Data Published for Boston Scientific’s Synergy Bioabsorbable EES

April 8, 2015 -- The 12-month data from the EVOLVE II were published by Dean J. Kereiakes, MD, et al online ahead of print in Circulation: Cardiovascular Interventions. EVOLVE…

EVERBIO II Compares Bioresorbable Vascular Scaffold to New-Generation Drug-Eluting Stents

March 2, 2015 -- Findings from the EVERBIO II study comparing the performance of a bioresorbable vascular scaffold (BVS) with that of everolimus-eluting stents (EES) and bioli…




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.